18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3555<br />

Podnositelj europske MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

prijave patenta<br />

(71) (51) (97) (54)<br />

Maria Clementine Martin Klosterfrau<br />

Vertriebsgesellschaft mbH, DE<br />

EP 1886690<br />

Maria Clementine Martin Klosterfrau<br />

Vertriebsgesellschaft mbH, DE<br />

A61K 36/185 (2006.01)<br />

A61K 31/352 (2006.01)<br />

A61K 38/47 (2006.01)<br />

A61K 31/4415 (2006.01)<br />

A61P 1/00 (2006.01)<br />

A61K 9/00 (2006.01)<br />

A61K 9/10 (2006.01)<br />

A61K 9/20 (2006.01)<br />

A61K 31/00 (2006.01)<br />

A61K 33/00 (2006.01)<br />

A61K 36/23 (2006.01)<br />

Markon Holdings Limited, NZ E03C 1/04 (2006.01)<br />

A47K 3/16 (2006.01)<br />

MARX, Thomas A., US A61B 17/132 (2006.01)<br />

Massachusetts Institute of Technology, C12N 15/10 (2006.01)<br />

US<br />

C12P 7/06 (2006.01)<br />

Mazence Inc., KR A61K 31/33 (2006.01)<br />

A61K 31/453 (2006.01)<br />

A61K 9/32 (2006.01)<br />

A61P 3/10 (2006.01)<br />

A61P 3/04 (2006.01)<br />

Mazence Inc., KR A61K 31/343 (2006.01)<br />

A61K 31/453 (2006.01)<br />

A61K 9/32 (2006.01)<br />

A61P 3/10 (2006.01)<br />

A61P 3/04 (2006.01)<br />

Mazence Inc., KR A61K 31/34 (2006.01)<br />

A61P 9/00 (2006.01)<br />

Mazence Inc., KR A61K 31/352 (2006.01)<br />

Mccool, James, US A61K 9/20 (2006.01)<br />

A61K 31/325 (2006.01)<br />

A61K 47/02 (2006.01)<br />

MeadWestvaco Corporation, US B65D 83/04 (2006.01)<br />

Merck & Co., Inc., US C07D 498/08 (2006.01)<br />

C07D 498/18 (2006.01)<br />

C07K 5/08 (2006.01)<br />

C07K 5/10 (2006.01)<br />

C07K 5/12 (2006.01)<br />

A61K 31/40 (2006.01)<br />

A61K 38/06 (2006.01)<br />

A61K 38/07 (2006.01)<br />

A61K 31/12 (2006.01)<br />

Merck & Co., Inc., US C07D 401/14 (2006.01)<br />

C07D 413/14 (2006.01)<br />

C07D 471/04 (2006.01)<br />

C07D 487/04 (2006.01)<br />

C07D 491/048 (2006.01)<br />

C07D 491/052 (2006.01)<br />

C07D 495/04 (2006.01)<br />

A61K 31/551 (2006.01)<br />

A61P 3/04 (2006.01)<br />

A61P 25/20 (2006.01)<br />

C07D 403/14 (2006.01)<br />

Merck & Co., Inc., US C07D 231/56 (2006.01)<br />

C07D 401/10 (2006.01)<br />

C07D 403/10 (2006.01)<br />

A61K 31/416 (2006.01)<br />

A61P 5/44 (2006.01)<br />

Merck & Co., Inc., US C07D 231/56 (2006.01)<br />

C07D 401/10 (2006.01)<br />

C07D 403/10 (2006.01)<br />

A61K 31/416 (2006.01)<br />

A61P 5/44 (2006.01)<br />

Merck Frosst Canada Ltd., CA C07D 413/14 (2006.01)<br />

A61K 31/454 (2006.01)<br />

A61P 3/00 (2006.01)<br />

C07D 417/14 (2006.01)<br />

Merial Limited, US A61K 39/08 (2006.01)<br />

Merial Limited, US A61M 5/00 (2006.01)<br />

Merial Ltd., US A61K 38/18 (2006.01)<br />

A61K 48/00 (2006.01)<br />

A61P 13/12 (2006.01)<br />

Merial Ltd., US A61K 39/02 (2006.01)<br />

A61P 31/04 (2006.01)<br />

Millennium Pharmaceuticals, Inc., US C07D 487/04 (2006.01)<br />

A61K 31/55 (2006.01)<br />

A61P 35/00 (2006.01)<br />

EP 2088999 *<br />

EP 2089580 *<br />

EP 2<strong>09</strong>9366 *<br />

EP 2<strong>09</strong>9910 *<br />

EP 2<strong>09</strong>4261 *<br />

EP 2<strong>09</strong>4262 *<br />

EP 2<strong>09</strong>9448 *<br />

EP 2<strong>09</strong>9449 *<br />

EP 2089002 *<br />

EP 2<strong>09</strong>1842 *<br />

EP 2086982 *<br />

EP 2089382 *<br />

EP 2<strong>09</strong>1922 *<br />

EP 2<strong>09</strong>7385 *<br />

EP 2<strong>09</strong>9793 *<br />

EP 2086580 *<br />

EP 2<strong>09</strong>4332 *<br />

EP 2<strong>09</strong>9472 *<br />

EP 2<strong>09</strong>9479 *<br />

EP 2086981 *<br />

Pharmaceutical composition for the treatment of food<br />

intolerance<br />

PHARMACEUTICAL COMPOSITION COMPRISING AN<br />

ACTIVE INGREDIENT WHICH NEUTRALIZES AND/OR<br />

BINDS GASTRIC ACID, SUCH AS AN ALGINIC ACID<br />

DERIVATIVE<br />

MOUNTING APPARATUS FOR BATH FITTING<br />

TOURNIQUET SYSTEM<br />

GLOBAL TRANSCRIPTION MACHINERY<br />

ENGINEERING<br />

PHARMACEUTICAL COMPOSITION CONTAINING<br />

NAPHTHOQUINONE-BASED COMPOUND FOR<br />

INTESTINE DELIVERY SYSTEM<br />

PHARMACEUTICAL COMPOSITION CONTAINING<br />

PHENANTHRENEQUINONE-BASED COMPOUND<br />

FOR INTESTINE DELIVERY SYSTEM<br />

PHARMACEUTICAL COMPOSITION FOR<br />

TREATMENT AND PREVENTION OF RESTENOSIS<br />

PHARMACEUTICAL COMPOSITION FOR THE<br />

TREATMENT AND PREVENTION OF DISEASES<br />

INVOLVING IMPOTENCE<br />

PHENYLALKYL CARBAMATE COMPOSITIONS<br />

BLISTER PACK SECONDARY PACKAGE<br />

HCV NS3 PROTEASE INHIBITORS<br />

SUBSTITUTED DIAZEPAN COMPOUNDS AS OREXIN<br />

RECEPTOR ANTAGONISTS<br />

2-[1-PHENYL-5-HYDROXY-4ALPHA-METHYL-<br />

HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL<br />

PHENYL DERIVATIVES AS GLUCOCORTICOID<br />

RECEPTOR LIGANDS<br />

2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-<br />

METHYL-HEXAHYDROCLOPENTA[F]INDAZOL-5-<br />

YL]ETHYL PHENYL DERIVATIVES AS<br />

GLUCOCORTICOID RECEPTOR LIGANDS<br />

AZACYCLOALKANE DERIVATIVES AS INHIBITORS<br />

OF STEAROYL-COENZYME A DELTA-9<br />

DESATURASE<br />

PRIME BOOST CANINE LEISHMANIA VACCINE<br />

MULTIPLE FLUID DELIVERY DEVICE FOR POULTRY<br />

INTRA-VASCULAR KIDNEY GENE THERAPY WITH<br />

PLASMID ENCODING BMP-7<br />

SALMONELLA VACCINE IN POULTRY<br />

COMPOUNDS FOR INHIBITING MITOTIC<br />

PROGRESSION<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!